Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

280.57
Delayed Data
As of 3:59pm ET
 +1.97 / +0.71%
Today’s Change
205.42
Today|||52-Week Range
307.33
+7.41%
Year-to-Date
Seeking Value in Biotech: Biogen
4:31pm / GuruFocus News - Paid Partner Content
Nektar (NKTR) Stock Rallied Almost 50% This Year: Here's Why
Jun 16 / Zacks.com - Paid Partner Content
Pharma recovers composure as price concerns ease
Jun 21 / FT.com - Paid Partner Content
Bear of the Day: Bioverativ (BIVV)
Jun 16 / Zacks.com - Paid Partner Content
Biogen Ready for a Big Bounce
Jun 21 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Management Changes at Biogen, Alexion, GILD Files HIV Drug
Jun 15 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: Clovis Soars on Rubraca Data, Seattle Hit by Study Halt
Jun 21 / Zacks.com - Paid Partner Content
Biogen Loses Top Executive Again, CFO Clancy to Join Alexion
Jun 14 / Zacks.com - Paid Partner Content
Biogen Upgraded at UBS on Alzheimer's Clinical Trial Progress
Jun 19 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close278.60
Today’s open279.86
Day’s range278.30 - 284.21
Volume2,838,940
Average volume (3 months)1,622,724
Market cap$59.1B
Dividend yield--
Data as of 3:59pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+1.37%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+9.37%
P/E ratio17.6
Price/Sales6.09
Price/Book4.95

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+2.98+4.41%
ILMNIllumina Inc+5.61+3.16%
BIVVBioverativ Inc-0.09-0.15%
KITEKite Pharma Inc+0.45+0.48%
Data as of 4:00pm ET, 06/22/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$4.54
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
VP-Finance, Chief Financial &
Accounting Officer
Gregory F. Covino
Corporate headquarters
Cambridge, Massachusetts

Forecasts